EquityScore
BETA

For Indian investment research teams

Put investment ideas to the test.

Company intelligence and maintained research infrastructure. Focus on your strategies. We take care of the foundation.

Built over two years · Designed for serious research

Company intelligenceRetained review

PRIVISCL.NSE

Privi Speciality Chemicals

21 October 2026 · Specialty chemicals

B
Risk componentsScore / 100
Business
79.7
Financial
57.9
Governance
69.2
Liquidity
55.4
Market
68.6
Valuation
Review separately20.1

Recorded change: C → B · Valuation 18.8 → 20.1

Read-only excerpt of retained outputs · not a live quote

What your team can do

Depth you can work with.

Company analysis, screens, watchlists and fund views are usable today. Ask the founder to arrange access.

Explore the full platform Eight specialist analyzers, connected by a master analysis layer.

Investigate companies

Sector-aware fundamentals, capital allocation and forensic checks.

Altman Z · Beneish M · Sloan accruals

Find research leads

Find companies through research screens. Inspect the reasons and counterpoints.

Quarterly trends · Opportunity lenses

Understand your coverage

Examine grade mix, risk patterns, sector concentration and overlap.

Watchlists · Funds · Portfolios

Review recorded changes

Compare dated grades, components and observations.

Research history · Component drivers

Inside the company review

The grade moved.
The business picture needs its own review.

FY2026 vs FY2025: group profit +71.4%, revenue +22.0%.Audited consolidated annual statements.

Review the reported earnings improvement separately from the recorded grade change. The cause of the valuation movement remains unresolved.

Explore the risk and accounting view
Retained company observations, 19 and 21 October 2026
Recorded item19 Oct21 Oct
Risk gradeCB
Valuation component18.820.1
Total penalty31.625.0
Other risk componentsUnchanged

The Evidence Engine

Examine what the evidence actually supports.

Screeners find companies. Evidence tools examine defined questions through statistical checks, comparisons and retained findings.

Failed and insufficient findings stay part of the research.

Shown in founder walkthroughs today · Self-service strategy testing planned

See how the Evidence Engine works
Evidence EngineReviewed claim

Grade A basket · Verdict corrected 12 Jul 2026 (UTC)

An apparent advantage. An unsupported conclusion.

Question
Did the Grade A basket demonstrate that the grades added value?
What review found
The basket used equal weights; NIFTY50 used market-cap weights. The comparison could not establish whether the grades explained the apparent advantage.
Verdict correction
PASS → INSUFFICIENT
The original supporting evidence could not be recovered.
Research action
Require a weight-matched comparison and traceable evidence before attributing the advantage to the grades.

Retained correction story · No performance claim

Why use our infrastructure

Your research.
A maintained foundation.

Models are only part of the work. Reporting periods, sector rules, company identities and history need continuing upkeep. Reuse those layers while your team focuses on its own research.

Your team owns

  • The thesis and private ideas
  • Research and investment judgment
  • Portfolio decisions

EquityScore maintains

  • Sector rules and analytical tools
  • Data and reporting-period checks
  • Company identities and recorded history

The bigger ambition · Planned

Turn funds, portfolios and watchlists into reusable research definitions—then keep observing and testing specific claims as evidence matures.

Explore it with the founder

Bring one company.
Or one research question.

Send your company or research question and a little context about your team.

Request a walkthrough

Or email contact@equityscore.in

About the product views and access

These are dated company observations and a retained claim correction, not live quotes or a completed validation.

Product access is arranged with the founder. Grades classify; they do not forecast returns.

EquityScore — Research intelligence and evidence